PRCC and renal cell carcinoma: Furthermore, we identified the top 100 proteogenomic DE markers in each RCC subtype (Figure S2I; Table S3) and noted their distinct enrichment among benign nephron cell types (Figure 2D), for example MAPRE3 in RO and PIGR in pRCC, which are described in later sections.